AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

NIAID

NIH launches largest clinical trial focused on HIV-related cardiovascular disease

nhlbi logo

Researchers have begun enrolling participants in a multicenter international clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events, such as heart attacks, strokes, and heart disease, in people with HIV infection. The trial is supported by the National Institutes of Health’s National Heart, Lung, and Blood Institute (NHLBI)…

NIH, South African Medical Research Council award $8 million in HIV, TB grants

nih logo

The National Institutes of Health and the South African Medical Research Council (SAMRC) are awarding 31 grants to U.S. and South African scientists to support research targeting HIV/AIDS, tuberculosis and HIV-related co-morbidities and cancers. The awards, which total $8 million in first-year funding, are the first to be issued through the South Africa–U.S. Program for…

NIH-led study to assess community-based hepatitis C treatment in Washington, D.C.

nih logo

For Immediate Release: Friday, March 6, 2015 Officials from the National Institutes of Health and the city of Washington, D.C., launched a clinical trial to examine whether primary care physicians and other health care providers, such as nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians to treat…

NIH-led study to assess community-based hepatitis C treatment in Washington, D.C.

nih logo

Officials from the National Institutes of Health and the city of Washington, D.C., launched a clinical trial to examine whether primary care physicians and other health care providers, such as nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians to treat people with hepatitis C virus (HCV) infection….

Conversations from CROI 2015: Dr. Gina Brown and Dr. Ron Valdiserri on Microbicides, Women and HIV

Gina Brown and Ron Validiserri

As we approach the annual observance of National Women and Girls HIV/AIDS Awareness Day next week, we wanted to share another interview we captured at the 2015 Conference on Retroviruses and Opportunistic Infections  (CROI). While at CROI in Seattle last week, Dr. Ronald Valdiserri, Deputy Assistant Secretary for Health, Infectious Diseases, spoke with Dr. Gina…

Final CROI 2015 Highlights from NIH’s Dr. Carl Dieffenbach

Carl Dieffenbach - NIH - CROI2015

As the 2015 Conference on Retroviruses and Opportunistic Infections (CROI)  in Seattle came to a close on Thursday, February 26, we spoke again with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID) about a highlight from the day’s presentations as well as his reflections as the…

More CROI 2015 Highlights from NIH’s Dr. Carl Dieffenbach (Video)

IMG_6944

After another day full of presentations on the latest in HIV science at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI)  in Seattle yesterday, February 25, we had the opportunity to speak again with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID). He shared…

NIH’s Dr. Carl Dieffenbach Shares Highlights from First Day of CROI 2015 (Video)

Carl Dieffenbach - NIH - CROI2015

After the first full day of sessions at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI)  in Seattle yesterday, February 24, we caught up with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), to get his take on some of the key highlights of…